Federico Ribet

Federico Ribet

Auto-generated profile, based on publicly available information

Federico Ribet

Department of Micro and Nanosystems, KTH Royal Institute of Technology, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2018 in Biomedical Microdevices
Verified
Journal Article
Open access
PDF file
FRFederico Ribet
Federico Ribet
GSGöran Stemme
Göran Stemme
NRNiclas Roxhed
Niclas Roxhed
Continuous glucose monitoring (CGM) has the potential to greatly improve diabetes management. The aim of this work is to show a proof-of-concept CGM device which performs minimally invasive and minimally delayed in-situ glucose sensing in the dermal interstitial fluid, combining the advantages of microneedle-based and commercially available CGM systems. The device is based on the integration of an ultra-miniaturized electrochemical sensing probe in the lumen of a single hollow microneedle, separately realized using standard silicon microfabrication methods. By placing the sensing electrodes inside the lumen facing an opening towards the dermal space, real-time measurement purely can be performed relying on molecular diffusion over a short distance. Furthermore, the device relies only on passive capillary lumen filling without the need for complex fluid extraction mechanisms. Importantly, the transdermal portion of the device is 50 times smaller than that of commercial products. This allows access to the dermis and simultaneously reduces tissue trauma, along with being virtually painless during insertion. The three-electrode enzymatic sensor alone was previously proven to have satisfactory sensitivity (1.5 nA/mM), linearity (up to 14 mM), selectivity, and long-term stability (up to 4 days) in-vitro. In this work we combine this sensor technology with microneedles for reliable insertion in forearm skin. In-vivo human tests showed the possibility to correctly and dynamically track glycaemia over time, with approximately 10 min delay with respect to capillary blood control values, in line with the expected physiological lag time. The proposed device can thus reduce discomfort and potentially enable less invasive real-time CGM in diabetic patients.

1 April 2017 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
FRFederico Ribet
Federico Ribet
GSGöran Stemme
Göran Stemme
NRNiclas Roxhed
Niclas Roxhed

21 February 2023 in Advanced Healthcare Materials
Verified
Journal Article
Open access
FRFederico Ribet
Federico Ribet
ABAnnika Bendes
Annika Bendes
CFClaudia Fredolini
Claudia Fredolini
MDMikolaj Dobielewski
Mikolaj Dobielewski
MBMichael Böttcher
Michael Böttcher
NRNiclas Roxhed
Niclas Roxhed
Blood sampling is a common practice to monitor health, but it entails a series of drawbacks for patients including pain and discomfort. Thus, there is a demand for more convenient ways to obtain samples. Modern analytical techniques enable monitoring of multiple bioanalytes in smaller samples, opening possibilities for new matrices, and microsampling technologies to be adopted. Interstitial fluid (ISF) is an attractive alternative matrix that shows good correlation with plasma concentration dynamics for several analytes and can be sampled in a minimally invasive and painless manner from the skin at the point‐of‐care. However, there is currently a lack of sampling devices compatible with clinical translation. Here, to tackle state‐of‐the‐art limitations, a cost‐effective and compact single‐microneedle‐based device designed to painlessly collect precisely 1.1 µL of dermal ISF within minutes is presented. The fluid is volume‐metered, dried, and stably stored into analytical‐grade paper within the microfluidic device. The obtained sample can be mailed to a laboratory, quantitatively analyzed, and provide molecular insights comparable to blood testing. In a human study, the possibility to monitor various classes of molecular analytes is demonstrated in ISF microsamples, including caffeine, hundreds of proteins, and SARS‐CoV‐2 antibodies, some being detected in ISF for the first time.

1 August 2018 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
FRFederico Ribet
Federico Ribet
LPLuca De Pietro
Luca De Pietro
NRNiclas Roxhed
Niclas Roxhed
GSGöran Stemme
Göran Stemme

12 August 2019 in Applied Physics Letters
Verified
Journal Article
Closed access
PDF file
FRF. Ribet
F. Ribet
ELE. De Luca
E. De Luca
FOF. Ottonello-Briano
F. Ottonello-Briano
MSM. Swillo
M. Swillo
NRNiclas Roxhed
Niclas Roxhed
GSG. Stemme
G. Stemme
This article reports a broad-band optical shutter based on microdroplet actuation with zero optical insertion loss in the open state. These features are achieved by electrowetting-on-dielectric (EWOD) actuation of opaque ionic liquid microdroplets. The negligible vapor pressure of ionic liquids allows the device to robustly operate in open air, unlike previously proposed EWOD-based systems in which the light crosses several attenuating and reflective layers, preventing broad-band operation and creating insertion losses > 14%. The presented device provides an attenuation of 78 dB in the closed state and a transmission of >99.99999% in the open state and can operate in the visible and mid-infrared wavelength range. Moreover, the switch can sustain larger incoming laser powers (5 mW continuous exposure or up to 3 h of continuous exposure at ∼100 mW) compared to the values reported for other state-of-the-art EWOD-based shutters. Additionally, the proposed device is compact, operates with low voltage (<25 V peak voltage), and features zero static power consumption.

24 February 2020 in Microsystems & Nanoengineering
Verified
Journal Article
Open access
PDF file
FRFederico Ribet
Federico Ribet
XWXiaojing Wang
Xiaojing Wang
MLMiku Laakso
Miku Laakso
SPSimone Pagliano
Simone Pagliano
FNFrank Niklaus
Frank Niklaus
GSGöran Stemme
Göran Stemme
The out-of-plane integration of microfabricated planar microchips into functional three-dimensional (3D) devices is a challenge in various emerging MEMS applications such as advanced biosensors and flow sensors. However, no conventional approach currently provides a versatile solution to vertically assemble sensitive or fragile microchips into a separate receiving substrate and to create electrical connections. In this study, we present a method to realize vertical magnetic-field-assisted assembly of discrete silicon microchips into a target receiving substrate and subsequent electrical contacting of the microchips by edge wire bonding, to create interconnections between the receiving substrate and the vertically oriented microchips. Vertical assembly is achieved by combining carefully designed microchip geometries for shape matching and striped patterns of the ferromagnetic material (nickel) on the backside of the microchips, enabling controlled vertical lifting directionality independently of the microchip’s aspect ratio. To form electrical connections between the receiving substrate and a vertically assembled microchip, featuring standard metallic contact electrodes only on its frontside, an edge wire bonding process was developed to realize ball bonds on the top sidewall of the vertically placed microchip. The top sidewall features silicon trenches in correspondence to the frontside electrodes, which induce deformation of the free air balls and result in both mechanical ball bond fixation and around-the-edge metallic connections. The edge wire bonds are realized at room temperature and show minimal contact resistance (168 mN in pull tests). In our approach, the microchips and the receiving substrate are independently manufactured using standard silicon micromachining processes and materials, with a subsequent heterogeneous integration of the components. Thus, this integration technology potentially enables emerging MEMS applications that require 3D out-of-plane assembly of microchips.